nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP2C9—Leflunomide—systemic scleroderma	0.0527	0.389	CbGbCtD
Alprazolam—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0486	0.359	CbGbCtD
Alprazolam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0189	0.14	CbGbCtD
Alprazolam—CYP3A4—Prednisone—systemic scleroderma	0.0151	0.112	CbGbCtD
Alprazolam—Abdominal pain—Azathioprine—systemic scleroderma	0.000797	0.000921	CcSEcCtD
Alprazolam—Body temperature increased—Azathioprine—systemic scleroderma	0.000797	0.000921	CcSEcCtD
Alprazolam—Skin disorder—Lisinopril—systemic scleroderma	0.000794	0.000919	CcSEcCtD
Alprazolam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000792	0.000916	CcSEcCtD
Alprazolam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00079	0.000914	CcSEcCtD
Alprazolam—Diarrhoea—Captopril—systemic scleroderma	0.00079	0.000914	CcSEcCtD
Alprazolam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000789	0.000913	CcSEcCtD
Alprazolam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000789	0.000912	CcSEcCtD
Alprazolam—Irritability—Methotrexate—systemic scleroderma	0.000788	0.000912	CcSEcCtD
Alprazolam—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000787	0.000911	CcSEcCtD
Alprazolam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000784	0.000907	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000784	0.000907	CcSEcCtD
Alprazolam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000783	0.000905	CcSEcCtD
Alprazolam—Mood swings—Methotrexate—systemic scleroderma	0.000782	0.000905	CcSEcCtD
Alprazolam—Nausea—Mometasone—systemic scleroderma	0.000781	0.000903	CcSEcCtD
Alprazolam—Anorexia—Lisinopril—systemic scleroderma	0.000779	0.000902	CcSEcCtD
Alprazolam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000778	0.0009	CcSEcCtD
Alprazolam—Weight increased—Prednisone—systemic scleroderma	0.000777	0.000899	CcSEcCtD
Alprazolam—Ataxia—Methotrexate—systemic scleroderma	0.000776	0.000898	CcSEcCtD
Alprazolam—Constipation—Mycophenolic acid—systemic scleroderma	0.000776	0.000898	CcSEcCtD
Alprazolam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000776	0.000897	CcSEcCtD
Alprazolam—Weight decreased—Prednisone—systemic scleroderma	0.000773	0.000894	CcSEcCtD
Alprazolam—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000772	0.000892	CcSEcCtD
Alprazolam—Hypotension—Lisinopril—systemic scleroderma	0.000764	0.000884	CcSEcCtD
Alprazolam—Dizziness—Captopril—systemic scleroderma	0.000763	0.000883	CcSEcCtD
Alprazolam—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000762	0.000882	CcSEcCtD
Alprazolam—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000761	0.00088	CcSEcCtD
Alprazolam—Depression—Prednisone—systemic scleroderma	0.000759	0.000878	CcSEcCtD
Alprazolam—Urticaria—Leflunomide—systemic scleroderma	0.000756	0.000874	CcSEcCtD
Alprazolam—Abdominal pain—Leflunomide—systemic scleroderma	0.000752	0.00087	CcSEcCtD
Alprazolam—Body temperature increased—Leflunomide—systemic scleroderma	0.000752	0.00087	CcSEcCtD
Alprazolam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000748	0.000865	CcSEcCtD
Alprazolam—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000747	0.000864	CcSEcCtD
Alprazolam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000747	0.000864	CcSEcCtD
Alprazolam—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000747	0.000864	CcSEcCtD
Alprazolam—Breast disorder—Methotrexate—systemic scleroderma	0.000746	0.000863	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000745	0.000862	CcSEcCtD
Alprazolam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000745	0.000861	CcSEcCtD
Alprazolam—Hypersensitivity—Azathioprine—systemic scleroderma	0.000742	0.000859	CcSEcCtD
Alprazolam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000742	0.000859	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000742	0.000858	CcSEcCtD
Alprazolam—Insomnia—Lisinopril—systemic scleroderma	0.00074	0.000855	CcSEcCtD
Alprazolam—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000738	0.000854	CcSEcCtD
Alprazolam—Paraesthesia—Lisinopril—systemic scleroderma	0.000734	0.000849	CcSEcCtD
Alprazolam—Vomiting—Captopril—systemic scleroderma	0.000734	0.000849	CcSEcCtD
Alprazolam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000731	0.000845	CcSEcCtD
Alprazolam—Dyspnoea—Lisinopril—systemic scleroderma	0.000729	0.000843	CcSEcCtD
Alprazolam—Rash—Captopril—systemic scleroderma	0.000728	0.000842	CcSEcCtD
Alprazolam—Dermatitis—Captopril—systemic scleroderma	0.000727	0.000841	CcSEcCtD
Alprazolam—Somnolence—Lisinopril—systemic scleroderma	0.000727	0.000841	CcSEcCtD
Alprazolam—Headache—Captopril—systemic scleroderma	0.000723	0.000837	CcSEcCtD
Alprazolam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000836	CcSEcCtD
Alprazolam—Dyspepsia—Lisinopril—systemic scleroderma	0.00072	0.000833	CcSEcCtD
Alprazolam—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000718	0.00083	CcSEcCtD
Alprazolam—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000718	0.00083	CcSEcCtD
Alprazolam—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000716	0.000829	CcSEcCtD
Alprazolam—Infection—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000823	CcSEcCtD
Alprazolam—Decreased appetite—Lisinopril—systemic scleroderma	0.000711	0.000822	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000706	0.000817	CcSEcCtD
Alprazolam—Fatigue—Lisinopril—systemic scleroderma	0.000705	0.000815	CcSEcCtD
Alprazolam—Shock—Mycophenolate mofetil—systemic scleroderma	0.000705	0.000815	CcSEcCtD
Alprazolam—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000703	0.000813	CcSEcCtD
Alprazolam—Hypersensitivity—Leflunomide—systemic scleroderma	0.000701	0.000811	CcSEcCtD
Alprazolam—Constipation—Lisinopril—systemic scleroderma	0.000699	0.000809	CcSEcCtD
Alprazolam—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000809	CcSEcCtD
Alprazolam—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000696	0.000805	CcSEcCtD
Alprazolam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000801	CcSEcCtD
Alprazolam—Diarrhoea—Azathioprine—systemic scleroderma	0.000689	0.000797	CcSEcCtD
Alprazolam—Nausea—Captopril—systemic scleroderma	0.000686	0.000793	CcSEcCtD
Alprazolam—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000684	0.000791	CcSEcCtD
Alprazolam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000683	0.00079	CcSEcCtD
Alprazolam—Asthenia—Leflunomide—systemic scleroderma	0.000683	0.00079	CcSEcCtD
Alprazolam—Hallucination—Prednisone—systemic scleroderma	0.00068	0.000787	CcSEcCtD
Alprazolam—Feeling abnormal—Lisinopril—systemic scleroderma	0.000674	0.000779	CcSEcCtD
Alprazolam—Pruritus—Leflunomide—systemic scleroderma	0.000673	0.000779	CcSEcCtD
Alprazolam—Connective tissue disorder—Prednisone—systemic scleroderma	0.000672	0.000777	CcSEcCtD
Alprazolam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000669	0.000774	CcSEcCtD
Alprazolam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000669	0.000773	CcSEcCtD
Alprazolam—Dysuria—Methotrexate—systemic scleroderma	0.000667	0.000772	CcSEcCtD
Alprazolam—Dizziness—Azathioprine—systemic scleroderma	0.000666	0.000771	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000663	0.000767	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000755	CcSEcCtD
Alprazolam—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000651	0.000753	CcSEcCtD
Alprazolam—Asthenia—Mycophenolic acid—systemic scleroderma	0.000651	0.000753	CcSEcCtD
Alprazolam—Diarrhoea—Leflunomide—systemic scleroderma	0.000651	0.000753	CcSEcCtD
Alprazolam—Urticaria—Lisinopril—systemic scleroderma	0.00065	0.000751	CcSEcCtD
Alprazolam—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000749	CcSEcCtD
Alprazolam—Body temperature increased—Lisinopril—systemic scleroderma	0.000646	0.000748	CcSEcCtD
Alprazolam—Abdominal pain—Lisinopril—systemic scleroderma	0.000646	0.000748	CcSEcCtD
Alprazolam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000643	0.000744	CcSEcCtD
Alprazolam—Pruritus—Mycophenolic acid—systemic scleroderma	0.000642	0.000743	CcSEcCtD
Alprazolam—Vomiting—Azathioprine—systemic scleroderma	0.000641	0.000741	CcSEcCtD
Alprazolam—Eye disorder—Prednisone—systemic scleroderma	0.000639	0.000739	CcSEcCtD
Alprazolam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000639	0.000739	CcSEcCtD
Alprazolam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000637	0.000737	CcSEcCtD
Alprazolam—Infestation—Methotrexate—systemic scleroderma	0.000636	0.000736	CcSEcCtD
Alprazolam—Infestation NOS—Methotrexate—systemic scleroderma	0.000636	0.000736	CcSEcCtD
Alprazolam—Drowsiness—Methotrexate—systemic scleroderma	0.000636	0.000736	CcSEcCtD
Alprazolam—Rash—Azathioprine—systemic scleroderma	0.000635	0.000735	CcSEcCtD
Alprazolam—Dermatitis—Azathioprine—systemic scleroderma	0.000635	0.000734	CcSEcCtD
Alprazolam—Depression—Methotrexate—systemic scleroderma	0.000635	0.000734	CcSEcCtD
Alprazolam—Headache—Azathioprine—systemic scleroderma	0.000631	0.00073	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000631	0.00073	CcSEcCtD
Alprazolam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000631	0.000729	CcSEcCtD
Alprazolam—Dizziness—Leflunomide—systemic scleroderma	0.000629	0.000728	CcSEcCtD
Alprazolam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000623	0.00072	CcSEcCtD
Alprazolam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000621	0.000718	CcSEcCtD
Alprazolam—Angiopathy—Prednisone—systemic scleroderma	0.00062	0.000717	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000619	0.000715	CcSEcCtD
Alprazolam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000709	CcSEcCtD
Alprazolam—Sweating—Methotrexate—systemic scleroderma	0.00061	0.000706	CcSEcCtD
Alprazolam—Vomiting—Leflunomide—systemic scleroderma	0.000605	0.0007	CcSEcCtD
Alprazolam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000602	0.000697	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000602	0.000696	CcSEcCtD
Alprazolam—Dizziness—Mycophenolic acid—systemic scleroderma	0.0006	0.000694	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—systemic scleroderma	0.0006	0.000694	CcSEcCtD
Alprazolam—Rash—Leflunomide—systemic scleroderma	0.0006	0.000694	CcSEcCtD
Alprazolam—Dermatitis—Leflunomide—systemic scleroderma	0.000599	0.000693	CcSEcCtD
Alprazolam—Mental disorder—Prednisone—systemic scleroderma	0.000599	0.000693	CcSEcCtD
Alprazolam—Nausea—Azathioprine—systemic scleroderma	0.000599	0.000692	CcSEcCtD
Alprazolam—Headache—Leflunomide—systemic scleroderma	0.000596	0.00069	CcSEcCtD
Alprazolam—Malnutrition—Prednisone—systemic scleroderma	0.000595	0.000688	CcSEcCtD
Alprazolam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000683	CcSEcCtD
Alprazolam—Asthenia—Lisinopril—systemic scleroderma	0.000587	0.000679	CcSEcCtD
Alprazolam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000586	0.000678	CcSEcCtD
Alprazolam—Pruritus—Lisinopril—systemic scleroderma	0.000578	0.000669	CcSEcCtD
Alprazolam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000577	0.000668	CcSEcCtD
Alprazolam—Rash—Mycophenolic acid—systemic scleroderma	0.000572	0.000662	CcSEcCtD
Alprazolam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000572	0.000661	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—systemic scleroderma	0.000571	0.000661	CcSEcCtD
Alprazolam—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000658	CcSEcCtD
Alprazolam—Headache—Mycophenolic acid—systemic scleroderma	0.000569	0.000658	CcSEcCtD
Alprazolam—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000655	CcSEcCtD
Alprazolam—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000655	CcSEcCtD
Alprazolam—Nausea—Leflunomide—systemic scleroderma	0.000565	0.000654	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000564	0.000653	CcSEcCtD
Alprazolam—Vision blurred—Prednisone—systemic scleroderma	0.000561	0.000649	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—systemic scleroderma	0.00056	0.000648	CcSEcCtD
Alprazolam—Diarrhoea—Lisinopril—systemic scleroderma	0.000559	0.000647	CcSEcCtD
Alprazolam—Ill-defined disorder—Prednisone—systemic scleroderma	0.000552	0.000639	CcSEcCtD
Alprazolam—Agitation—Prednisone—systemic scleroderma	0.000547	0.000632	CcSEcCtD
Alprazolam—Angioedema—Prednisone—systemic scleroderma	0.000544	0.000629	CcSEcCtD
Alprazolam—Dizziness—Lisinopril—systemic scleroderma	0.000541	0.000625	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—systemic scleroderma	0.00054	0.000625	CcSEcCtD
Alprazolam—Nausea—Mycophenolic acid—systemic scleroderma	0.000539	0.000624	CcSEcCtD
Alprazolam—Malaise—Prednisone—systemic scleroderma	0.000537	0.000621	CcSEcCtD
Alprazolam—Vertigo—Prednisone—systemic scleroderma	0.000535	0.000618	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—systemic scleroderma	0.000534	0.000617	CcSEcCtD
Alprazolam—Syncope—Prednisone—systemic scleroderma	0.000534	0.000617	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—systemic scleroderma	0.000533	0.000616	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—systemic scleroderma	0.00053	0.000613	CcSEcCtD
Alprazolam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000528	0.000611	CcSEcCtD
Alprazolam—Loss of consciousness—Prednisone—systemic scleroderma	0.000523	0.000605	CcSEcCtD
Alprazolam—Vomiting—Lisinopril—systemic scleroderma	0.00052	0.000601	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—systemic scleroderma	0.000518	0.000599	CcSEcCtD
Alprazolam—Rash—Lisinopril—systemic scleroderma	0.000516	0.000596	CcSEcCtD
Alprazolam—Convulsion—Prednisone—systemic scleroderma	0.000516	0.000596	CcSEcCtD
Alprazolam—Dermatitis—Lisinopril—systemic scleroderma	0.000515	0.000596	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000515	0.000595	CcSEcCtD
Alprazolam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000514	0.000595	CcSEcCtD
Alprazolam—Chills—Methotrexate—systemic scleroderma	0.000513	0.000593	CcSEcCtD
Alprazolam—Headache—Lisinopril—systemic scleroderma	0.000512	0.000592	CcSEcCtD
Alprazolam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000586	CcSEcCtD
Alprazolam—Arthralgia—Prednisone—systemic scleroderma	0.000507	0.000586	CcSEcCtD
Alprazolam—Myalgia—Prednisone—systemic scleroderma	0.000507	0.000586	CcSEcCtD
Alprazolam—Anxiety—Prednisone—systemic scleroderma	0.000505	0.000584	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000503	0.000582	CcSEcCtD
Alprazolam—Discomfort—Prednisone—systemic scleroderma	0.000501	0.000579	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—systemic scleroderma	0.0005	0.000579	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—systemic scleroderma	0.000497	0.000575	CcSEcCtD
Alprazolam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00049	0.000567	CcSEcCtD
Alprazolam—Nausea—Lisinopril—systemic scleroderma	0.000486	0.000562	CcSEcCtD
Alprazolam—Oedema—Prednisone—systemic scleroderma	0.000486	0.000562	CcSEcCtD
Alprazolam—Infection—Prednisone—systemic scleroderma	0.000482	0.000558	CcSEcCtD
Alprazolam—Back pain—Methotrexate—systemic scleroderma	0.000481	0.000556	CcSEcCtD
Alprazolam—Shock—Prednisone—systemic scleroderma	0.000478	0.000553	CcSEcCtD
Alprazolam—Nervous system disorder—Prednisone—systemic scleroderma	0.000476	0.000551	CcSEcCtD
Alprazolam—Tachycardia—Prednisone—systemic scleroderma	0.000474	0.000548	CcSEcCtD
Alprazolam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000548	CcSEcCtD
Alprazolam—Skin disorder—Prednisone—systemic scleroderma	0.000472	0.000546	CcSEcCtD
Alprazolam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000469	0.000543	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—systemic scleroderma	0.000469	0.000542	CcSEcCtD
Alprazolam—Anorexia—Prednisone—systemic scleroderma	0.000463	0.000535	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000461	0.000534	CcSEcCtD
Alprazolam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000527	CcSEcCtD
Alprazolam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000522	CcSEcCtD
Alprazolam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000522	CcSEcCtD
Alprazolam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000519	CcSEcCtD
Alprazolam—Malaise—Methotrexate—systemic scleroderma	0.000448	0.000519	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—systemic scleroderma	0.000447	0.000517	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000442	0.000512	CcSEcCtD
Alprazolam—Insomnia—Prednisone—systemic scleroderma	0.000439	0.000508	CcSEcCtD
Alprazolam—Paraesthesia—Prednisone—systemic scleroderma	0.000436	0.000504	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—systemic scleroderma	0.000431	0.000498	CcSEcCtD
Alprazolam—Dyspepsia—Prednisone—systemic scleroderma	0.000427	0.000494	CcSEcCtD
Alprazolam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000492	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—systemic scleroderma	0.000423	0.00049	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—systemic scleroderma	0.000423	0.00049	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—systemic scleroderma	0.000423	0.00049	CcSEcCtD
Alprazolam—Decreased appetite—Prednisone—systemic scleroderma	0.000422	0.000488	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00042	0.000486	CcSEcCtD
Alprazolam—Fatigue—Prednisone—systemic scleroderma	0.000419	0.000484	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—systemic scleroderma	0.000418	0.000484	CcSEcCtD
Alprazolam—Constipation—Prednisone—systemic scleroderma	0.000415	0.00048	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—systemic scleroderma	0.000409	0.000473	CcSEcCtD
Alprazolam—Infection—Methotrexate—systemic scleroderma	0.000403	0.000466	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisone—systemic scleroderma	0.0004	0.000463	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—systemic scleroderma	0.000398	0.00046	CcSEcCtD
Alprazolam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000397	0.000459	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—systemic scleroderma	0.000394	0.000456	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000392	0.000454	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—systemic scleroderma	0.000387	0.000447	CcSEcCtD
Alprazolam—Urticaria—Prednisone—systemic scleroderma	0.000386	0.000446	CcSEcCtD
Alprazolam—Abdominal pain—Prednisone—systemic scleroderma	0.000384	0.000444	CcSEcCtD
Alprazolam—Body temperature increased—Prednisone—systemic scleroderma	0.000384	0.000444	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—systemic scleroderma	0.000379	0.000439	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00037	0.000428	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—systemic scleroderma	0.000367	0.000425	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—systemic scleroderma	0.000364	0.000422	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—systemic scleroderma	0.000362	0.000419	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—systemic scleroderma	0.000361	0.000417	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisone—systemic scleroderma	0.000358	0.000414	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—systemic scleroderma	0.000357	0.000413	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—systemic scleroderma	0.000353	0.000408	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00035	0.000405	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—systemic scleroderma	0.00035	0.000405	CcSEcCtD
Alprazolam—Asthenia—Prednisone—systemic scleroderma	0.000348	0.000403	CcSEcCtD
Alprazolam—Pruritus—Prednisone—systemic scleroderma	0.000344	0.000397	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000334	0.000387	CcSEcCtD
Alprazolam—Diarrhoea—Prednisone—systemic scleroderma	0.000332	0.000384	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000332	0.000384	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—systemic scleroderma	0.000322	0.000373	CcSEcCtD
Alprazolam—Dizziness—Prednisone—systemic scleroderma	0.000321	0.000371	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—systemic scleroderma	0.000321	0.000371	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—systemic scleroderma	0.000321	0.000371	CcSEcCtD
Alprazolam—Vomiting—Prednisone—systemic scleroderma	0.000309	0.000357	CcSEcCtD
Alprazolam—Rash—Prednisone—systemic scleroderma	0.000306	0.000354	CcSEcCtD
Alprazolam—Dermatitis—Prednisone—systemic scleroderma	0.000306	0.000354	CcSEcCtD
Alprazolam—Headache—Prednisone—systemic scleroderma	0.000304	0.000352	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000299	0.000346	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—systemic scleroderma	0.000291	0.000337	CcSEcCtD
Alprazolam—Nausea—Prednisone—systemic scleroderma	0.000288	0.000334	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—systemic scleroderma	0.000287	0.000332	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—systemic scleroderma	0.000278	0.000321	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—systemic scleroderma	0.000268	0.00031	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—systemic scleroderma	0.000258	0.000298	CcSEcCtD
Alprazolam—Rash—Methotrexate—systemic scleroderma	0.000256	0.000296	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—systemic scleroderma	0.000256	0.000296	CcSEcCtD
Alprazolam—Headache—Methotrexate—systemic scleroderma	0.000254	0.000294	CcSEcCtD
Alprazolam—Nausea—Methotrexate—systemic scleroderma	0.000241	0.000279	CcSEcCtD
